Contributors |
|
xiii | |
Preface |
|
xvii | |
|
1 Evolution of proopiomelanocortin |
|
|
1 | (16) |
|
|
|
Jose Miguel Cerda-Reverter |
|
|
|
1 | (1) |
|
2 Evolution of opioid peptides and nociceptin/orphanin family |
|
|
2 | (8) |
|
|
10 | (3) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
13 | (4) |
|
2 Structure and dynamics of dynorphin peptide and its receptor |
|
|
17 | (32) |
|
|
|
|
|
1 Dynorphin: A neuropeptide involved in pain, addiction and mood regulation |
|
|
18 | (4) |
|
2 The molecular mechanism of action of dynorphin: Research and hypotheses prior to KOP cloning |
|
|
22 | (2) |
|
3 KOP cloning, site-directed mutagenesis and heterologous expression systems |
|
|
24 | (2) |
|
4 Structure and dynamics of dynorphin and its receptor based on experimental 3D structures |
|
|
26 | (4) |
|
5 Building 3D models of dynorphin-KOP complexes |
|
|
30 | (3) |
|
6 Development of novel KOP ligands based on structural knowledge |
|
|
33 | (1) |
|
7 Conclusions and future perspectives |
|
|
34 | (1) |
|
|
35 | (14) |
|
3 Molecular aspects of delta opioid receptors |
|
|
49 | (42) |
|
|
|
|
|
|
1 The delta opioid receptor (DOP) |
|
|
50 | (1) |
|
2 Advances in the resolution of GPCR structures |
|
|
51 | (10) |
|
3 Trafficking of DOP to the plasma membrane |
|
|
61 | (5) |
|
4 Molecular mechanisms of DOP signaling |
|
|
66 | (4) |
|
5 Molecular mechanisms underlying regulation of DOP signaling |
|
|
70 | (6) |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
76 | (15) |
|
4 The role of heat shock protein 90 in regulating pain, opioid signaling, and opioid antinociception |
|
|
91 | (14) |
|
|
|
92 | (1) |
|
|
93 | (2) |
|
3 Hsp90 in opioid signaling and antinociception |
|
|
95 | (3) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
99 | (6) |
|
5 Enkephalinase regulation |
|
|
105 | (26) |
|
|
|
|
Magdalena Martinez-Canamero |
|
|
|
|
1 Enkephalins and enkephalinases |
|
|
106 | (2) |
|
2 Brain distribution and development (regional and subcellular) |
|
|
108 | (4) |
|
|
112 | (3) |
|
|
115 | (3) |
|
|
118 | (1) |
|
|
119 | (2) |
|
7 Neurotransmitters interactions |
|
|
121 | (3) |
|
8 Conclusions and future directions |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (7) |
|
6 Limbic circuit connectivity and the stress response: New insights into the mammalian nociceptin peptide system |
|
|
131 | (16) |
|
|
|
1 Mechanisms underlying the stress modulatory effects of the neuropeptide nociceptin |
|
|
132 | (2) |
|
2 Neuropharmacological basis of nociceptin effects in stress and anxiety |
|
|
134 | (2) |
|
3 Stress and the thalamic reticular nucleus |
|
|
136 | (3) |
|
4 Nociceptin and neurodevelopmental disorders |
|
|
139 | (1) |
|
|
140 | (1) |
|
|
141 | (4) |
|
|
145 | (2) |
|
7 Enkephalins and ACTH in the mammalian nervous system |
|
|
147 | (48) |
|
|
|
|
|
148 | (1) |
|
|
148 | (2) |
|
3 Structure of the enkephalin/ACTH genes |
|
|
150 | (1) |
|
4 Processing of the precursors |
|
|
151 | (3) |
|
|
154 | (4) |
|
6 Receptors and signaling cascades |
|
|
158 | (4) |
|
|
162 | (7) |
|
|
169 | (12) |
|
9 Conclusion and future perspectives |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
182 | (13) |
|
8 Opioids and the hormone oxytocin |
|
|
195 | (32) |
|
|
|
|
196 | (1) |
|
2 Effects of endogenous and exogenously administered opioids on brain OT systems |
|
|
197 | (8) |
|
3 Effects of endogenous and exogenously administered oxytocin on opioid use disorders |
|
|
205 | (4) |
|
|
209 | (6) |
|
|
215 | (1) |
|
|
216 | (9) |
|
|
225 | (2) |
|
9 Estrogens as arbiters of sex-specific and reproductive cycle-dependent opioid analgesic mechanisms |
|
|
227 | |
|
|
|
|
|
228 | (2) |
|
2 Sexually dimorphic opioid mechanisms mediate comparable opioid analgesia |
|
|
230 | (1) |
|
3 Influence of estrogens on the physical relationship of MOR and KOR |
|
|
231 | (1) |
|
4 Estrogens can influence the balance between antinociception and pronociception induced by dynorphin-KOR signaling |
|
|
232 | (1) |
|
5 Spinal ER-mGluRl signaling suppresses EM2 analgesia |
|
|
233 | (1) |
|
6 Estrogenic signaling suppresses endogenous spinal EM2 release |
|
|
234 | (1) |
|
7 Estrogenic signaling enables coordination of spinal EM2 utilization with physiological demand |
|
|
235 | (1) |
|
8 Collaboration between spinally- and ovarian-produced estrogens |
|
|
235 | (1) |
|
9 Multiple subpopulations of CNS aromatase and mERα |
|
|
236 | (3) |
|
|
239 | (1) |
|
|
239 | (1) |
|
|
239 | (8) |
|
10 Opioids and reproduction |
|
|
247 | (1) |
|
|
|
|
|
|
248 | (1) |
|
2 Effects of opioids in the central nervous system on the reproductive system |
|
|
249 | (6) |
|
3 Peripheral action of the opioid system |
|
|
255 | (6) |
|
4 Pathophysiology of the opioid system in reproductive disorders |
|
|
261 | (4) |
|
|
265 | (5) |
|
|
270 | (1) |
|
|
271 | (10) |
|
11 Kappa opioid receptor and oligodendrocyte remyelination |
|
|
281 | (1) |
|
|
|
1 Oligodendrocyte and remyelination |
|
|
282 | (3) |
|
2 Opioids in regulating oligodendroglial differentiation |
|
|
285 | (4) |
|
3 Endogenous opioid signaling in oligodendroglia |
|
|
289 | (2) |
|
|
291 | (1) |
|
|
291 | (8) |
|
12 Inhibitory role of Gi-coupled receptors on cAMP-driven cancers with focus on opioid receptors in lung adenocarcinoma and its stem cells |
|
|
299 | (1) |
|
|
|
300 | (1) |
|
2 Antagonistic effects of Gs- and Gi-coupled receptors on pulmonary adenocarcinoma and its stem cells |
|
|
301 | (4) |
|
3 Anti-carcinogenic effects of methadone |
|
|
305 | (1) |
|
4 Anti-carcinogenic effects of cannabinoids |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
307 | (6) |
|
13 Prenatal ethanol exposure and enkephalinergic neurotransmission |
|
|
313 | (1) |
|
|
|
|
|
314 | (2) |
|
2 Alcohol reinforcement: Activation of dopaminergic mesocorticolimbic transmission |
|
|
316 | (1) |
|
3 Role of opioid peptides in alcohol reinforcement |
|
|
317 | (1) |
|
4 Alcohol effects on enkephalinergic and β-endorphinergic transmission |
|
|
318 | (13) |
|
|
331 | (1) |
|
|
331 | |